van Tilburg CM, Kilburn LB, Perreault S, Schmidt R, et al. LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration. BMC Cancer 2024;24:147.
PMID: 38291372